Chemotherapy

Clinical Trials

• Randomized Study of Sildenafil Citrate During & After Radiotherapy/Hormone Therapy for Erectile Ftn Vs Radiotherapy/Hormone Therapy for Prostate Cancer
• Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer
• Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy
• A Long Term Safety Study With Atrasentan
• Androgen Suppression Alone or Combined With Zoledronate, Docetaxel, Prednisolone, and/or Celecoxib in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
• Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
• Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
• Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
• Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer
• Hormone Therapy in Treating Men With Stage IV Prostate Cancer
• Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
• Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
• GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
• Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
• Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
• Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
• Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer
• Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
• Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
• Docetaxel in Combination With GVAX ® Vaccine Versus Docetaxel and Prednisone in Prostate Cancer Patients
• CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)
• Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers
• Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
• The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis
• Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer
• Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP
• Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
• Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
• Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
• Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
• ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases
• Study, Investigating the Efficacy and Safety of Degarelix One Month Dosing Regimens
• Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
• Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
• Double-Blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-Refractory Prostate Cancer
• Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
• Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
• Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
• A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Therapy With ELIGARD
• EBRT With or Without Short-Course Hormone Therapy In Intermediate Risk Prostate Cancer Patients
• XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer (TROPIC)
• Randomized Trial of Immediate vs Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Ca After Rx
• Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
• Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer
• Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
• Combidex USPIO - Ultra-Small Superparamagnetic Iron Oxide
• Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
• Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With Hormone Refractory Prostate Cancer
• Ixabepilone, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy
• Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer
• A Study to Evaluate the Safety and Feasibility of Using OGX-011 in Combination With Second Line Chemotherapy in Patients With Hormone Refractory Prostate Cancer
• Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer
• Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-Independent Prostate Cancer
• Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
• Acupuncture Treatment for Hot Flashes Study
• Phase I/II Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer
• Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
• ET-743 in Men With Advanced Prostate Cancer
• Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
• Ixabepilone in Treating Patients With Metastatic Prostate Cancer
• APC8015F in Treating Patients With Progressive Metastatic Prostate Cancer and Disease-Related Pain
• Docetaxel, Bevacizumab, Thalidomide, and Prednisone in Treating Patients With Metastatic Androgen-Independent Prostate Cancer
• Sorafenib in Treating Patients With Metastatic Prostate Cancer
• Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer
• Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
• Cilengitide in Treating Patients With Metastatic Prostate Cancer
• Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer
• Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
• Docetaxel With or Without Dimethylxanthenone Acetic Acid (AS1404) in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
• Cilengitide in Treating Patients With Prostate Cancer
• Fulvestrant in Treating Patients With Recurrent Prostate Cancer
• Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer
• Etoposide and Cyclophosphamide in Treating Patients With Stage D0 Prostate Cancer
• Transdermal Estradiol in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy and Chemotherapy
• Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer
• Study Of SU011248 In Combination With Docetaxel (Taxotere.) And Prednisone In Patients With Prostate Cancer
• ET 743 (Yondelis) in Men With Advanced Prostate Cancer
• Exisulind Versus Placebo After Surgical Removal of the Prostate
• Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
• A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
• A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
• Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
• A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients.
• Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
• Effect of Casodex on Tumour Hypoxia - Prostate Cancer

Please log-in or register in order to submit comments.

Powered by AkoComment!